NEJM Interview: Rebecca Haffajee on the rescheduling of medical marijuana products and its potential effect on research.
About this episode
Rebecca Haffajee discusses the implications of rescheduling medical marijuana products on research.
Rebecca Haffajee is a professor in the Department of Health Policy and Management at the Yale School of Public Health. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. R.L. Haffajee, R.A. Mikos, and Z.D. Cooper. Marijuana Rescheduling — A Game Changer for Research? N Engl J Med 2026;395:729-731.
People in this episode
Host: Stephen Morrissey
Guest: Rebecca Haffajee
Topics covered
- medical marijuana
- research impact
- health policy
- drug rescheduling
- public health
Keywords
- medical marijuana
- research
- rescheduling
- health policy
- Yale School of Public Health
Mentioned in this episode
Organizations: Yale School of Public Health, NEJM
Books & works: Marijuana Rescheduling — A Game Changer for Research?
More episodes of NEJM Interviews
- NEJM Interview: Elizabeth Kaplan on changes to the U.S. Preventive Services Task Force and the importance of evidence-based recommendations for preventive services.
- NEJM Interview: Elizabeth Tobin-Tyler on the legal argument that permitting telehealth access to mifepristone can abet reproductive coercion.
- NEJM Interview: Eric Schneider on the limitations of pay-for-performance programs and alternative options to support quality improvement.
- NEJM Interview: Jean Nachega on the importance of investment in equitable partnerships, community trust, and local scientific leadership for outbreak preparedness.
- NEJM Interview: Jerry Avorn on the role of litigation in addressing product-related damage to health.
- NEJM Interview: Arnold Monto on the value and feasibility of various methods for evaluating the protection offered by vaccines.
Explore listener stats, chart rankings, contacts and more on the NEJM Interviews podcast page.